Observational studyHuman vaccines & immunotherapeutics2026

Efficacy and safety of radiofrequency hyperthermia combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma: A propensity score-matched study.

Yangjun Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.